Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma

Leukemia

Volumn 24, Issue 5, 2010, Pages 1084-1086

  Hockley, S L ^a   Morilla, A ^a   Else, M ^a   Dearden, C ^a   Catovsky, D ^a   Morgan, G J ^a   Matutes, E ^a   Gonzalez, D ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN HEAVY CHAIN;

COHORT ANALYSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; GENE MUTATION; HAIRY CELL LEUKEMIA; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS; SPLENIC MARGINAL ZONE LYMPHOMA; TUMOR DIFFERENTIATION;

EID: 77952338253     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.44     Document Type: Letter

References (11)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organisation Classification of Tumours. IARC Press: Lyon, France, 2008.
2. Weill JC, Weller S, Reynaud CA. Human marginal zone B cells. Annu Rev Immunol 2009; 27: 267-285.
3. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553-563.
4. Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003; 101: 3574-3580.
5. Oppezzo P, Dumas G, Lalanne AI, Payelle-Brogard B, Magnac C, Pritsch O et al. Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells. Blood 2005; 105: 2495-2503.
6. Hockley SL, Giannouli S, Morilla A, Wotherspoon A, Morgan GJ, Matutes E et al. Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns. Br J Haematol 2010; 148: 666-669.
7. Matutes E, Morilla R, Owusu-Ankomah K, Houliham A, Meeus P, Catovsky D. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma 1994; 14: 57-61.
8. Matutes E, Wotherspoon A, Catovsky D. The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol 2003; 16: 41-56.
9. Forconi F, Sozzi E, Rossi D, Sahota SS, Amato T, Raspadori D et al. Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia. Haematologica 2008; 93: 697-705.
10. Basso K, Liso A, Tiacci E, Benedetti R, Pulsoni A, Foa R et al. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. J Exp Med 2004; 199: 59-68.
11. Traverse-Glehen A, Davi F, Ben Simon E, Callet-Bauchu E, Felman P, Baseggio L et al. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Haematologica 2005; 90: 470-478.